Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, anabasum, is a novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. It is currently being evaluated in four clinical programs: systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus.

Type
Public
HQ
Norwood, US
Founded
2009
Size (employees)
25 (est)
Corbus Pharmaceuticals was founded in 2009 and is headquartered in Norwood, US
Report incorrect company information

Corbus Pharmaceuticals Office Locations

Corbus Pharmaceuticals has an office in Norwood
Norwood, US (HQ)
103 100 River Ridge Dr
Show all (1)
Report incorrect company information

Corbus Pharmaceuticals Financials and Metrics

Corbus Pharmaceuticals Financials

USD

Net income (Q1, 2018)

(11.7 m)

EBIT (Q1, 2018)

(11.9 m)

Market capitalization (14-Jun-2018)

348.6 m

Closing share price (14-Jun-2018)

6.1

Cash (31-Mar-2018)

71 m

EV

278 m
Corbus Pharmaceuticals's current market capitalization is $348.6 m.
Annual
USDFY, 2017

General and administrative expense

9 m

R&D expense

26 m

Operating expense total

35 m

EBIT

(32.6 m)
Quarterly
USDQ1, 2018

General and administrative expense

3.1 m

R&D expense

9.8 m

Operating expense total

12.8 m

EBIT

(11.9 m)
Annual
USDFY, 2017

Cash

62.5 m

Current Assets

65.5 m

PP&E

1.4 m

Total Assets

67 m
Quarterly
USDQ1, 2018

Cash

71 m

Current Assets

74.5 m

PP&E

2.6 m

Total Assets

77.1 m
Annual
USDFY, 2017

Net Income

(32.4 m)

Depreciation and Amortization

255.7 k

Accounts Payable

(885.8 k)

Cash From Operating Activities

(27.8 m)
Quarterly
USDQ1, 2018

Net Income

(11.7 m)

Depreciation and Amortization

81.9 k

Accounts Payable

1.2 m

Cash From Operating Activities

(1.6 m)
USDY, 2018

EV/EBIT

-23.4 x

EV/CFO

-173.8 x

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Corbus Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information

Corbus Pharmaceuticals News and Updates

Report incorrect company information